STOCK TITAN

Celestica SEC Filings

CLS NYSE

Welcome to our dedicated page for Celestica SEC filings (Ticker: CLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Celestica Inc. filings document operating results, governance actions, capital-structure matters, and shareholder communications for a Canadian issuer with common shares registered under CLS on the New York Stock Exchange.

Recent disclosures include Form 8-K reports for quarterly and annual financial results, Regulation FD communications, board and committee transitions, annual meeting records, material-event reporting, and share repurchase authorization. The definitive proxy statement covers director elections, executive compensation, shareholder voting procedures, governance policies, and related proxy matters for Celestica’s public-company oversight.

Rhea-AI Summary

Celestica Inc. director Jill Kale reported routine equity compensation activity. On March 31, 2026, she exercised 287 Restricted Share Units (RSUs) into 287 Common Shares at $0.00 per share and had 17 Common Shares withheld at $257.27 per share to cover tax obligations.

She also received a new grant of 276 RSUs, each representing a contingent right to one Common Share or cash. Following these transactions, she directly holds 270 Common Shares and continues to hold RSUs granted on March 31, 2025 and March 31, 2026 that vest over three years.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Colpron Francoise reported acquisition or exercise transactions in this Form 4 filing.

Celestica Inc. director Francoise Colpron received an equity award of 296 restricted share units on March 31, 2026. These RSUs were granted as compensation and give a contingent right to receive one common share or an equivalent cash amount for each unit.

According to the terms, one third of the 296 RSUs vests each year over three years on the anniversary of the grant date, so the award becomes fully vested over time rather than immediately.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Celestica Inc. director Robert Cascella reported routine equity compensation activity tied to restricted share units (RSUs). On March 31, 2026, he exercised 156 RSUs into the same number of common shares and received a new grant of 150 RSUs that vest in three annual installments starting on the grant anniversary. To cover tax obligations from the RSU vesting, 9 common shares were withheld at $257.27 per share, leaving him with 147 common shares directly held. After the transactions, he continues to hold 312 RSUs from a prior 468-unit grant in addition to the new 150-unit RSU award.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Ahuja Kulvinder reported acquisition or exercise transactions in this Form 4 filing.

Celestica Inc. director Kulvinder Ahuja received a grant of 138 Director Share Units. These units are a form of deferred compensation tied to the company’s common shares. After this award, Ahuja holds 633 Director Share Units in total.

Each Director Share Unit represents a right to receive one common share or an equivalent cash amount, at Celestica’s discretion, when the holder stops serving as a director, consultant or other service provider.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Celestica Inc. director Michael Max Wilson exercised equity awards and settled related taxes in shares. On March 31, 2026, he exercised restricted share units into 3,199 Common Shares and received an additional 398 Director Share Units as a grant.

To cover tax obligations from the RSU vesting, 1,536 Common Shares were withheld at a price of $257.09 per share, converted from Canadian dollars. After these transactions, he directly held 20,210 Common Shares, reflecting a modest net increase from compensation-related awards rather than open-market trading.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Celestica Inc. announced a planned board leadership transition and the appointment of a new independent director. Chair Michael Wilson will retire and not stand for re-election at the 2026 annual meeting, consistent with the company’s director retirement policy and with no disagreement over operations or governance.

Effective immediately before the 2026 annual meeting on May 19, 2026, President and CEO Rob Mionis will become Chair of the Board, and long-time director Laurette Koellner will serve as Lead Independent Director, providing independent oversight and leading executive sessions of independent directors. The board also appointed David Reeder as an independent director effective May 1, 2026 and named him to the Audit, Human Resources and Compensation, and Nominating and Corporate Governance Committees.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.23%
Tags
current report
Rhea-AI Summary

CLS notice: a proposed sale of 39,492 shares of Common Stock is listed as a compensatory payment dated 03/17/2026.

The excerpt also records a prior sale of 37 shares on 02/20/2026 for $10,703.29 by Luis Muller and identifies Kevin Reavey in the filer information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Summary

Celestica Inc. files its annual report describing a fast-growing, AI-focused electronics design and manufacturing business built around two segments: Connectivity and Cloud Solutions (CCS) and Advanced Technology Solutions (ATS). CCS serves hyperscalers and other data center customers with servers, storage, networking and rack-level platforms, increasingly under its Hardware Platform Solutions (HPS) original design model.

CCS revenue reached $9.19 billion in 2025, up from $6.49 billion in 2024, with HPS growing 81% year over year and contributing 41% of total revenue. The business is highly concentrated: the top 10 customers generated 79% of 2025 revenue, and three CCS customers accounted for 32%, 14% and 12%, respectively. Revenue is shifting toward Communications, which represented 57% of total revenue in 2025, while ATS declined to 26%.

The company emphasizes global manufacturing, supply chain and engineering depth, with about 29,591 employees and roughly 75% of revenue produced in Asia. Extensive risk disclosures highlight dependence on a limited customer base, cyclical hyperscaler spending, component supply, AI and data center infrastructure constraints, and broader macro, regulatory and environmental factors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
-
Rhea-AI Summary

Celestica Inc. president Todd C. Cooper reported a charitable gift of company stock. On February 6, 2026, he transferred 15,600 common shares of Celestica to a donor-advised fund, which will use the shares for charitable purposes.

After this gift, Cooper directly beneficially owned 93,370 common shares of Celestica. The transaction was reported as a gift (code G) at a price of $0 per share, reflecting that no cash changed hands in connection with the transfer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Celestica Inc. insider plans a Rule 144 stock sale. A holder has filed to sell 120,000 Celestica common shares through Janney Montgomery Scott LLC / Stirling Wealth Management on the NYSE, with an aggregate market value of $33,103,200.00. The approximate sale date indicated is February 5, 2026, and Celestica had 115,036,621 common shares outstanding.

The shares to be sold come from prior equity awards. They were received upon vesting of share units from Celestica Inc. in four transactions: 90,643 shares on February 4, 2026; 10,852 shares on December 2, 2025; 15,575 shares on February 2, 2023; and 2,930 shares on February 1, 2023, each settled as common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many Celestica (CLS) SEC filings are available on StockTitan?

StockTitan tracks 114 SEC filings for Celestica (CLS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Celestica (CLS)?

The most recent SEC filing for Celestica (CLS) was filed on April 2, 2026.